Using single-cell analysis, researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found that previously identified subtypes for colorectal cancer may not offer nuanced tumor classification.
Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer, announced a collaborative agreement with Thermo Fisher Scientific Inc. through its subsidiary Life Technologies Corporation.
